Bio

Silas is the Senior Director leading Market Access Scientific and External Strategy for Janssen Scientific Affairs.  His team shapes scientific strategy, develops policy evidence, and engages with external experts and researchers to demonstrate the value of pharmaceutical innovation and enable patient access.  Silas had been with Janssen/Johnson & Johnson for more than 20 years, working on health economics, healthcare quality, outcomes research and market access.  He has also engaged with health plans, health systems, and quality measurement organizations to support the Triple Aim. Currently, Silas is a member of the Task Force on Low Value Care led by VBID Health and multiple industry market access and research work groups.